Live feed08:00:00·28mPRReleasevia QuantisnowIMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without ModificationByQuantisnow·Wall Street's wire, on your screen.IMNN· Imunon Inc.Health Care
